ZNF713

Across TCGA pan-cancer cohorts, ZNF713 RNA is linked to patient survival in 20 of 34 cancer types, making it the most broadly survival-associated ZNF713 data layer compared with 7 for mutation status and 1 for mass-spec protein.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher ZNF713 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ZNF713 expression acts as an unfavorable survival marker, although some lineages such as UCS and THYM show a favorable association.

LIHC, ACC, and UCS are the cancer types where ZNF713 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Quartile	II,III,IV	0.426	0.800	<.001	83	view →
ACC	DFS	Tertile	All	0.452	0.796	<.001	32	view →
UCS	OS	Tertile	IV	0.844	0.228	.024	30	view →
THYM	DFS	Quartile	All	1.000	0.505	.003	24	view →
GBM	OS	Tertile	All	0.616	0.272	.001	23	view →
LUSC	DFS	Median	III,IV	0.540	0.763	.005	20	view →
LGG	OS	Median	All	0.753	0.903	<.001	20	view →
MESO	DFS	Tertile	All	0.239	0.705	.006	18	view →
SCLC	DFS	Median	II,III,IV	0.612	0.307	.005	12	view →
KICH	DFS	Quartile	II,III,IV	0.223	0.832	.010	12	view →
KIRC	OS	Median	All	0.897	0.850	.017	12	view →
THCA	OS	Median	All	0.964	1.000	.015	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 20 lineages.

ZNF713–LIHC (OS)

Open the LIHC breakdown →